FDA warns against using 26 eye drop products due to infection risk
FDA warns against using 26 eye drop products due to infection risk
00:33
The FDA has expanded its list of eye drops recalled in 2023 because the products could be tainted with bacteria.
Store-brand products sold at retailers including CVS, Rite Aid, Target and Walmart are included in the latest recall, posted on Wednesday by the federal safety agency. The recall by Kilitch Healthcare India cited “safety concerns” after FDA investigators found unsanitary conditions at the facility where the products were made.
The FDA has cited a “risk of eye infections that could result in partial vision loss or blindness” in cautioning consumers against using the now-recalled products in late October. FDA investigators found bacteria in samples taken from the production plant, the agency noted in its warning. As of Nov. 13, Kilitch said it hasn’t received any reports of adverse health effects linked to the recall.
Eye drops recalled in most recent round
Many of the eye drops are likely no longer in stores, as the FDA said CVS, Rite Aid and Target were removing the products from store shelves and websites.
The recall notice urged distributors and retailers to stop selling the products and for consumers to return them.
Amazon removes 7 eye drop products from site after FDA warning
Amazon said its website was no longer offering seven eye drop products after the FDA warned the e-commerce giant that their distribution violated federal regulations and raised public health concerns.
The pulled products named in the agency’s letter are: Similasan Pink Eye Relief, The Goodbye Company Pink Eye, Can-C Eye Drops, Optique 1
